Long-acting anticholinergic agents in patients with uncontrolled asthma: A systematic review and meta-analysis

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 12, 2014, Pages 1421-1430

  Lee, S W ^a   Kim, H J ^b   Yoo, K H ^c   Park, Y B ^d   Park, J Y ^e   Jung, J Y ^f   Moon, J Y ^g   Byun, M K ^h   Kim, S W ⁱ   Kim, Y H ^j  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Hallym University   (South Korea)

^e Wonkwang University   (South Korea)

^f Yonsei University   (South Korea)

^g Hanyang University College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Ewha Womans University   (South Korea)

^j Kyung Hee University Hospital   (South Korea)

more..

Author keywords

Anticholinergics; Asthma; Tiotropium

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PLACEBO; TIOTROPIUM BROMIDE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE DERIVATIVE;

ASTHMA; BRONCHODILATING ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; CHI SQUARE DISTRIBUTION; DRUG COMBINATION; DRUG EFFECTS; LUNG; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; CHOLINERGIC ANTAGONISTS; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; ODDS RATIO; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84911377328     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0275     Document Type: Review

References (26)

1. Juniper E F, Kline P A, Vanzieleghem M A, Ramsdale E H, O'Byrne P M, Hargreave F E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832-836.
2. Bateman E D, Boushey H A, Bousquet J, et al. Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836-844.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2012 update. Bethesda, MD, USA: GINA, 2012. http: //www.ginasthma.org/Accessed September 2014.
4. Bateman E D, Bousquet J, BusseWW, et al. Stability of asthma control with regular treatment: An analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy 2008; 63: 932-938.
5. Chanez P, Wenzel S E, Anderson G P, et al. Severe asthma in adults: What are the important questions? J Allergy Clin Immunol 2007; 119: 1337-1348.
6. Fardon T C, Lee D K, Haggart K, McFarlane L C, Lipworth B J. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004; 170: 960-966.
7. van Staa T P, Leufkens H G, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 2001; 16: 581-588.
8. Pavord I D, Brightling C E, Woltmann G, Wardlaw A J. Noneosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-2214.
9. Motomura C, Odajima H, Tezuka J, Harada J, Okada K, Nishima S. Perception of dyspnea during acetylcholine-induced bronchoconstriction in asthmatic children. Ann Allergy Asthma Immunol 2009; 102: 121-124.
10. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999; 107: 363-370.
11. Lanes S F, Garrett J E, Wentworth C E, 3rd, Fitzgerald J M, Karpel J P. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: A pooled analysis of three trials. Chest 1998; 114: 365-372.
12. Fardon T, Haggart K, Lee D K, Lipworth B J. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007; 101: 1218-1228.
13. Bateman E D, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri L M. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128: 315-322.
14. Kerstjens H A, Disse B, Schroder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. J Allergy Clin Immunol 2011; 128: 308-314.
15. Kerstjens H A, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012; 367: 1198-1207.
16. Peters S P, Kunselman S J, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715-1726.
17. Tashkin D P, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
18. Lofdahl C G, Chung K F. Long-acting beta 2-adrenoceptor agonists: A new perspective in the treatment of asthma. Eur Respir J 1991; 4: 218-226.
19. Nelson H S. Beta-adrenergic bronchodilators. N Engl J Med 1995; 333: 499-506.
20. Arvidsson P, Larsson S, Lofdahl C G, Melander B, Svedmyr N, Wahlander L. Inhaled formoterol during one year in asthma: A comparison with salbutamol. Eur Respir J 1991; 4: 1168-1173.
21. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: Comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306: 1034-1037.
22. Wessler I K, Kirkpatrick C J. The Non-neuronal cholinergic system: An emerging drug target in the airways. Pulm Pharmacol Ther 2001; 14: 423-434.
23. Wessler I, Kilbinger H, Bittinger F, Kirkpatrick C J. The biological role of non-neuronal acetylcholine in plants and humans. Jpn J Pharmacol 2001; 85: 2-10.
24. Bateman E D, Rennard S, Barnes P J, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009; 22: 533-542.
25. Chung K F,Wenzel S E, Brozek J L, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.
26. Tian J W, Chen J W, Chen R, Chen X. Tiotropium versus placebo for inadequately controlled asthma: A meta-analysis. Respir Care 2014; 59: 654-666.